Source: s3://data.kl3m.ai/documents/govinfo/USCOURTS/USCOURTS-cand-3_07-cv-02845/USCOURTS-cand-3_07-cv-02845-29/pdf.json

Nature of Suit Code: 830
Nature of Suit: Patent
Cause of Action: 28:1338 Patent Infringement

---

United States District Court

For the Northern District of California

1

2

3

4

5

6

7

8

9

10

11

12

13

14

15

16

17

18

19

20

21

22

23

24

25

26

27

28

IN THE UNITED STATES DISTRICT COURT

FOR THE NORTHERN DISTRICT OF CALIFORNIA

APPLERA CORPORATION-APPLIED

BIOSYSTEMS GROUP, a Delaware

corporation,

Plaintiff,

 v.

ILLUMINA, INC., a Delaware corporation,

SOLEXA INC., a Delaware corporation,

and STEPHEN C. MACEVICZ, an

individual

Defendants. /

No. C 07-02845 WHA

ORDER RE LEAD COUNSEL

An order dated March 29, 2008, stated, “[t]o put an end to all discovery issues once and

for all, on the day of the bifurcation hearing, both lead counsel and someone with decisional

authority for each client shall meet and confer in person in the jury room to discuss every

outstanding discovery dispute” (Dkt. 173). The Court has been under the impression that

Attorney Kevin Flowers was defendants’ lead counsel. However, Attorney Flowers did not

even appear at the bifurcation hearing held on April 3, 2008. Nor did he in anyway seek relief

from the March 29 order. Accordingly, at trial Attorney Thomas Ross, who appeared at the

hearing on behalf of defendants, will serve as lead trial counsel. 

IT IS SO ORDERED.

Dated: April 4, 2008. WILLIAM ALSUP

UNITED STATES DISTRICT JUDGE

Case 3:07-cv-02845-WHA Document 182 Filed 04/04/08 Page 1 of 1